Chromostatin is a 20-residue peptide derived from chromogranin A (CGA), the major soluble component of secretory granules in adrenal meduliary chromaffin cells. One known biological function of chromostatin is to inhibit the secretagogue-evoked catecholamine secretion from chromaffin cells. Putative receptors are present on the chromaffin-cell plasma membrane, and the activation of such receptors leads to the inhibition of L-type voltage-sensitive calcium channels.
to the inhibition of L-type voltage-sensitive calcium channels.
We report here that exposure of chromaffin cells to chromostatin modifies neither cAMP and cGMP levels nor protein kinase C activity but does provoke the activation of soluble protein phosphatase (PPase) type 2A in a dose-dependent manner compatible with the peptide concentration inhibiting catecholamine secretion. The activation of the PPase as well as the inhibition of both secretagogue-induced Ca2+ entry and catecholamine secretion by chromostatin were all blocked by okadaic acid, a specific PPase inhibitor. We suggest that chromostatin directly or indirectly stimulates PPase-2A, dephosphorylating a target protein and lowering its activity in the secretory process.
Chromogranin A (CGA) is a member of a family of acidic secretory proteins, the chromogranins/secretogranins, which are widely distributed in peptidergic endocrine cells and neurons (1) . At the subcellular level, CGA is found in the soluble core of hormone and neurotransmitter storage vesicles and is released from them by exocytosis after cell stimulation.
CGA remains the topic of many unanswered questions concerning its possible functions, although recent data suggest a possible prohormonal role in the autocrine and/or paracrine modulation ofregulated secretion. The sequence of pancreastatin, a 49-residue peptide from porcine pancreas inhibiting insulin secretion from endocrine pancreatic islets (2, 3) , amylase release from exocrine pancreas (4) , and acid secretion from parietal cells (5) , is fully contained within the sequence of porcine CGA. CGA is also the precursor of chromostatin, a peptide that exerts a negative-feedback control on the secretory activity of chromaffin cells (6, 7) . In addition, an inhibitory autocrine role of CGA on proopiomelanocortin secretion (8) and a regulatory role of aminoterminal CGA-derived peptides on the secretion of calcitonin gene-regulating products (9) and on vascular contractile responses (10) have been reported. Together these observations strongly support the view that CGA is a prohormone.
In a previous report, we described the purification of two -CGA-derived peptides active on catecholamine secretion from cultured chromaffin cells (7) . A corresponding 20-amino acid peptide named chromostatin was synthesized and found to completely inhibit catecholamine secretion in the nanomolar to micromolar range. Bovine chromaffin cells possess specific receptors for chromostatin the activation of which markedly decreases Ca2+ entry through voltage-gated L-type calcium channels (11) . The main purpose ofthe present study was to investigate how the inhibitory effect of chromostatin is achieved. We suggest that a protein phosphatase (PPase) may be responsible, at least partially, for the chromostatininduced inhibition of catecholamine release.
MATERIALS AND METHODS
[3H]Norepinephrine (Noradrenaline) Release Assay. Chromaffin cell cultures were prepared as in ref. 12 . Four-to six-day-old cultures were used for [3H]norepinephrine secretion, which was done and expressed as described in ref. 12 .
Protein Kinase C (PKC) Activity and Cyclic Nucleotide Measurements. PKC activity was determined as in ref. 13 . Measurement of cyclic nucleotide levels was done in chromaffin-cell supernatant with assay kits (Amersham), following the manufacturer's instructions.
45Ca2-Uptake Experiments. 45Ca2+ (13.5 mCi/mg of Ca; CaCl2 salt; New England Nuclear/DuPont; 1 Ci = 37 GBq) influx into cells was measured as described (14, 15) .
Determination of PPase Activity. Histone was phosphorylated with cAMP-dependent protein kinase as described by Zwiller et al. (16) , and the 32P-phosphorylated histone was recovered according to the procedure reported by Meisler and Langan (17) . Chromaffin cells were grown for 3-6 days at a density of 5 x 106 cells on 35-mm-diameter plastic dishes. After extensive washing, cells were incubated for 10 (18) . To ensure linearity, the dephosphorylation was kept within a limit of 20% conversion from the phosphorylated form.
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RESULTS
Effect of Chromostatin on Secretagogue-Induced Catecholamine Release from Chromaffin Cells. Previous work from our laboratory has shown that chromostatin produces a dosedependent inhibition of catecholamine secretion from chromaffin cells evoked by cholinergic agonists or by K+ at a depolarizing concentration (7) . Here the effects of chromostatin on catecholamine secretion induced by either 30 ,M veratridine, 100 uM histamine, or 10 uM Ca2+ ionophore X537A were compared. Fig. 1 shows that chromostatin produced a dose-dependent inhibition of catecholamine release evoked by carbamoylcholine or by direct depolarization with K+ or veratridine. Secretion after 10-min incubation with 100 nM chromostatin was inhibited by 80% in cells stimulated with carbamoylcholine and by 50% in directly depolarized cells. In contrast, chromostatin had no effect on secretion induced by histamine or by the calcium ionophore. Chromostatin inhibition on secretion, thus, depends on the secretagogue used to stimulate the cells, indicating that the observed effects may result from modifications occurring at the receptor level or subsequent to that level.
Effect of Chromostatin on the Cytoplasmic Concentration of Cyclic Nudeotides. In response to cholinergic stimulation, cAMP and cGMP levels in cultured chromaffin cells increased, respectively, from 300 + Effect of Chromostatin on PPase Activity. Okadaic acid is a potent and highly specific inhibitor of serine/threonine PPases-1 and -2A (21, 22) . Fig. 2 shows that secretion induced by carbamoylcholine or 59 mM K+ was not modified in cells pretreated for 20 min with 100 nM okadaic acid, a concentration known to inhibit both PPase-1 and PPase-2A. However, okadaic acid at 100 nM for 20 min or 50 nM for 4 hr had a dramatic effect on chromostatin-induced inhibition because it completely reversed the inhibitory effect of the peptide on catecholamine release evoked by both secretagogues. Only a partial reversion was obtained in cells treated for 24 hr with 10 nM okadaic acid (Fig. 2) .
We also measured 45Ca2+ entry into chromaffmi cells stimulated with carbamoylcholine or directly depolarized with high K+ in the presence or absence of chromostatin after preincubation with 100 nM okadaic acid. Fig. 3 Neurobiology: Galindo et chromostatin on Ca2+ uptake and catecholamine release may be mediated by a PPase. Table 1 shows the effects of several CGA-derived peptides on soluble PPase activity. Preincubation of chromaffin cells for 10 min with 100 nM chromostatin increased soluble PPase activity by 2-fold. In contrast, pancreastatin, CAP-14, and rat chromostatin, three CGA-derived peptides that do not inhibit catecholamine release from bovine chromaffin cells (11) , had no effect on soluble PPase activity.
Incubation of cells with increased chromostatin concentration produced a dose-dependent increase in the soluble PPase activity, whereas there was no apparent change in membrane-associated PPase activity (Fig. 4) . Maximal activation (128%) of soluble enzyme was observed with 10 nM soluble fraction of chromaffin cells: the IC50 for okadaic acid inhibition increased with increased enzyme concentrations, a phenomenon characterizing PPase-2A (23) . The observed IC50 (as low as 0.5 nM) is consistent with the PPase being of type 2A, as opposed to type 1, for which much higher okadaic acid concentration is required (23) . Moreover, >85% of the soluble PPase activity was abolished by 0.1 ,uM okadaic acid, suggesting that type 2A is largely predominant in chromaffincell cytosol. Treatment of cells with 100 nM chromostatin did not modify the IC50 for okadaic acid inhibition (Fig. 6 ).
DISCUSSION
The function of CGA, the major soluble component of secretory granules in both adrenal medullary chromaffm cells and in many other endocrine-cell types (1) appears to be that of a prohormone precursor of several biologically active peptides (2-11). Our previous work has shown that CGAderived peptides exert a negative-feedback control on chromaffin-cell secretory activity (6) , and the active peptide has been purified and partially sequenced (7). Chromostatin, a corresponding synthetic peptide composed of 20 amino acids produces a dose-dependent inhibition of the catecholamine secretion evoked by cholinergic agonists (7, 11) . Using radiolabeled chromostatin, we have demonstrated the existence of specific receptors for chromostatin on chromaffin cells grown in primary culture (11) . The purpose of the present study was to investigate the intracellular pathways coupled to activation of the chromostatin receptor. Pertussis toxin, which specifically blocks certain G proteins and potentiates the secretory response in chromafin cells (13), did not modify chromostatin inhibition (data not shown), excluding a coupling with pertussis toxin-sensitive G proteins. In addition, we did not find any modification of cyclic nucleotide levels or PKC activity alteration in cells treated with chromostatin, ruling out involvement of protein kinase A, protein kinase G, and PKC.
In contrast, we have found that the stimulation of the chromostatin receptor selectively activates a cytosolic PPase activity in chromaffin cells. The inhibitory effects of chromostatin on secretagogue-induced Ca2+ uptake and catecholamine secretion in cultured chromaffin cells are completely reversed by okadaic acid, a potent and specific inhibitor of several serine/threonine PPases, demonstrating further that the effects of chromostatin may be mediated by activation of PPases. No direct effect of chromostatin on cytosolic, particulate, or purified PPases was seen, suggesting that an indirect mechanism is responsible for the activation. However a direct mechanism of activation requiring the integrity of the membrane architecture cannot be ruled out.
The PPase type involved in this phenomenon was next characterized. Serine/threonine PPases have been divided into type 1 and type 2, depending on their ability to dephosphorylate preferentially the (3 or a subunit of phosphorylase kinase (25) . Recently, a type 3 PPase has been described, but it can be ruled out because this type, although sensitive to okadaic acid, is associated with the membrane fraction (26); we found no PPase stimulation in the particulate fraction after treatment of chromaffmi cells with chromostatin. Type 2 PPases can be subdivided into three distinct enzymes, PPase-2A, PPase-2B, and PPase-2C, the latter two showing an absolute requirement for Ca2+ and Mg2+, respectively, and being insensitive to nanomolar concentrations of okadaic acid. As PPase activation with chromostatin occurred in the absence of any added metal ion (Fig. 6 ) and was inhibited by okadaic acid, type 2B and 2C PPases can be excluded. Type 2A PPase, rather than type 1 PPase, appears to be the PPase involved in the chromostatin effect because (i) okadaic acid-induced inhibition depends on enzyme concentration and (ii) the IC50 value in both control and chromostatinstimulattd cells is in the nanomolar range. Type 2A, as shown from the okadaic acid-inhibition curve, is largely predominant in the cytosolic fraction of chromaffin cells, in agreement with a previous study (27) .
What is the target of this PPase type 2A, which once activated by chromostatin inhibits catecholamine secretion from chromaffin cells? From the lack of chromostatin effect on ionophore-and on histamine-induced secretion, the chromostatin-activated PPase is likely to act at a step before exocytosis. The observation that secretion evoked by depolarizing concentrations of K+ is only partially inhibited by chromostatin, whereas nicotine-induced secretion is totally blocked suggests that dephosphorylation probably occurs on multiple sites.
Activity of many receptors has been shown to depend on their phosphorylation state (28) (29) (30) . Although the chromaffin-cell acetylcholine receptor has not been studied so far, it is probable that its activity is under the control of a phosphorylation/dephosphorylation cycle. Therefore PPase type 2A may dephosphorylate a key component regulating receptor activity. It is noteworthy that chromostatin has no effect on histamine-evoked secretion, an indication that the histamine receptor is probably not a target of the PPase.
Because chromostatin partially blocks high K+-evoked secretion and reduces Ca2+ entry in stimulated cells as shown here and inhibits L-type calcium currents (11) , PPase activation may also affect voltage-gated calcium channels of the L-type. These L-type calcium channels are recruited on stimulation of cells with nicotine but not with histamine (31) . Several studies have demonstrated that the activity of voltage-sensitive calcium currents can be modulated by cyclic nucleotide-dependent pathways and/or PKC-dependent phosphorylation (32) (33) (34) (35) (36) . Armstrong and Eckert (34) have demonstrated that the dihydropyridine-sensitive L-type calcium channels in GH3 cells must be phosphorylated to open when the membrane is depolarized. In the bovine chromaffin cell, phosphorylation by protein kinase A seems to lead to activation of the L-type calcium channel (37) . Moreover, dephosphorylation inactivates the calcium channels by leav-7402 Neurobiology: Galindo et al.
ing them in a state in which they do not open in response to membrane depolarization (34, 38) . The role of PPase-2A in modulating ionic channel-gating kinetics has been recently described in rat brain (39) and cardiac muscle (40) . From these and other studies on channels in living tissue and on channels reconstituted in artificial bilayers (41) (42) (43) , it has been proposed that calcium-channel phosphorylation/ dephosphorylation cycle operates continuously and that channel gating and Ca2+ influx can be altered by modulating either the kinase or the phosphatase portion of the cycle. Here such a negative regulation of the L-type calcium channel through dephosphorylation by PPase type 2A might operate in response to stimulation of the receptor to chromostatin.
In conclusion, chromostatin inhibits catecholamine secretion from chromaffin cells by activating a soluble PPase type 2A. The targets of this enzyme are not yet characterized but are likely to be multiple, including plasma-membrane receptors and/or L-type calcium channels.
